Effectiveness of anti-psychotics and related drugs in the Huntington French-speaking group cohort.
PURPOSE: Huntington's disease is a rare condition. Patients are commonly treated with antipsychotics and tetrabenazine. The evidence of their effect on disease progression is limited and no comparative study between these drugs has been conducted. We therefore compared the effectiveness of anti...
Main Authors: | Gaëlle Désaméricq, Guillaume Dolbeau, Christophe Verny, Perrine Charles, Alexandra Durr, Katia Youssov, Clémence Simonin, Jean-Philippe Azulay, Christine Tranchant, Cyril Goizet, Philippe Damier, Emmanuel Broussolle, Jean-François Demonet, Graca Morgado, Laurent Cleret de Langavant, Isabelle Macquin-Mavier, Anne-Catherine Bachoud-Lévi, Patrick Maison |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3893200?pdf=render |
Similar Items
-
Longitudinal study of informed consent in innovative therapy research: experience and provisional recommendations from a multicenter trial of intracerebral grafting.
by: Laurent Cleret de Langavant, et al.
Published: (2015-01-01) -
COMT Val158Met Polymorphism Modulates Huntington's Disease Progression.
by: Ruth de Diego-Balaguer, et al.
Published: (2016-01-01) -
Insulin-Like Growth Factor-1 but Not Insulin Predicts Cognitive Decline in Huntington's Disease.
by: Linda Salem, et al.
Published: (2016-01-01) -
Neuroendocrine disturbances in Huntington's disease.
by: Nadine Saleh, et al.
Published: (2009-01-01) -
How to Capitalize on the Retest Effect in Future Trials on Huntington's Disease.
by: Catherine Schramm, et al.
Published: (2015-01-01)